• Home
  • Leadership
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Therapeutic Programs
  • Media
  • Contact
UNC-Chapel Hill gene therapy spinout raises $1.4 million

UNC-Chapel Hill gene therapy spinout raises $1.4 million

by Damon Race | Sep 12, 2022 | In the News

By Zac Ezzone  –  Staff writer, Triangle Business Journal Sep 1, 2022 A UNC-Chapel Hill spinout developing gene therapies focused on rare blood diseases and disorders has raised $1.4 million to support its efforts. The company, GeneVentiv Therapeutics, raised the...
UNC-Chapel Hill gene therapy spinout raises $1.4 million

Bootstrapped UNC spinout lands $300K for gene therapy work

by Damon Race | Jun 14, 2022 | In the News

The Old Well on the UNC-Chapel Hill campus. Mehmet Demirci By Zac Ezzone – Staff writer June 14, 2022, 08:52am EDT After bootstrapping for nearly two years, the CEO of a UNC-Chapel Hill spinout developing gene therapies has received some financial support. In...
Triangle gene therapy startup GeneVentiv Therapeutics awarded $250K loan from NC Biotech Center

Triangle gene therapy startup GeneVentiv Therapeutics awarded $250K loan from NC Biotech Center

by Damon Race | Jun 8, 2022 | In the News

Pixabay image by Jason Parker — June 8, 2022 RALEIGH – GeneVentiv Therapeutics, a Triangle-area pre-clinical gene therapy company, has been awarded a $250,000 Strategic Research Loan (SRL) from the North Carolina Biotechnology Center (NCBC). The loan will enable the...
GeneVentiv Therapeutics Receives Funding from the North Carolina Biotechnology Center

GeneVentiv Therapeutics Receives Funding from the North Carolina Biotechnology Center

by Damon Race | Jun 7, 2022 | Press

June 7, 2022 Damon R. Race, President & CEO RALEIGH, NC – GeneVentiv Therapeutics, a pre-clinical gene therapy company focused on blood diseases and disorders, today announced the award of a $250,000 Strategic Research Loan (SRL) from the North Carolina...

Recent Posts

  • GeneVentiv Invited to Present at The National Hemophilia Foundation’s 17th Workshop
  • GeneVentiv Expands Management Team and Board of Directors
  • UNC-Chapel Hill gene therapy spinout raises $1.4 million
  • Bootstrapped UNC spinout lands $300K for gene therapy work
  • Triangle gene therapy startup GeneVentiv Therapeutics awarded $250K loan from NC Biotech Center

Recent Comments

    Archives

    • February 2023
    • January 2023
    • September 2022
    • June 2022
    • March 2022
    • February 2022
    • November 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020

    Categories

    • In the News
    • Press

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    • Please prove you are human by selecting the Star.
    • This field is for validation purposes and should be left unchanged.

    Copyright © 2020 GeneVentiv Therapeutics. All rights reserved.